Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Core Insights - Catalyst Pharmaceuticals, Inc. has been ranked fifth in Forbes' list of America's Most Successful Mid-Cap Companies for 2025, showcasing its strong performance among 100 companies [1][2][3] - The ranking reflects Catalyst's continued growth, moving from fourth place in the previous year's list of Small-Cap Companies, indicating a positive trajectory in earnings, sales, return on equity, and total stock return over the last five years [2][3] Company Overview - Catalyst Pharmaceuticals is a biopharmaceutical company focused on improving the lives of patients with rare diseases, emphasizing the development and commercialization of innovative therapies [4] - The company has a strong commitment to patient care and accessibility, providing a comprehensive suite of support services to ensure patients receive necessary treatments [4] - Catalyst is headquartered in Coral Gables, Florida, and is actively seeking to expand its global presence through strategic partnerships, while also being recognized as one of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List [4]